|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.32 EUR | +0.14% |
|
+5.60% | +172.36% |
| 07-03 | Genfit soars on news of U.S. reimbursement for a product |  |
| 07-03 | Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 14.66 | 14.66 | 14.66 |
| Spread/Res. | -2.18% | -2.18% | -2.18% |
| Spread/Supp. | +20.30% | +49.84% | +111.19% |
| Support | 11.92 | 9.57 | 6.79 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- GNFT Stock
- Charts GENFIT
Select your edition
All financial news and data tailored to specific country editions
